EGEvelyne Gineyts

Evelyne Gineyts

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Evelyne Gineyts has a total of 109 co-authors. Here are the top co-authors by number of shared publications:

  • Helene Follet

    Univ Lyon, Univ Claude Bernard Lyon 1, INSERM, LYOS UMR 1033, 69008, Lyon, France

    7 shared publications
  • Olivier Borel

    Université de Lyon, Université Lyon 1, INSERM UMR 1033, LYOS Pathophysiology, Diagnosis & Treatments of Musculoskeletal Disorders , Lyon 69008

    5 shared publications
  • Delphine Farlay

    INSERM, UMR 1033, University of Lyon, University Claude Bernard Lyon 1, F69622, Lyon, France

    4 shared publications
  • Marjorie Millet

    INSERM U1033, Hopital Edouard Herriot, Lyon, France

    4 shared publications
  • Patrick Garnero

    Affiliations INSERM Unit 1033, Edouard Herriot Hospital, Lyon, France, PMOLab, Edouard Herriot Hospital, Lyon, France

    4 shared publications
  • Roland Chapurlat

    Service de rhumatologie, Hôpital Edouard Herriot, Hospices Civils de Lyon, université Claude-Bernard Lyon 1, Lyon, France; INSERM U1033, Hopital Edouard Herriot, Lyon, France

    4 shared publications

Latest Publications

  • Open Access

    Elevated periostin level in serum of adults with osteogenesis imperfecta is associated with disease severity

    by Alexandre Mercier-Guery, Maxime Auroux, Evelyne Gineyts, Olivier Borel, Pawel Szulc, Elisabeth Sornay-Rendu, Elisabeth Fontanges, Martine Croset, Jean-Charles Rousseau, Roland Chapurlat

    Objective: In osteogenesis imperfecta (OI), phenotypic variability and the limited predictive value of genotype–phenotype correlations underscore the need for reliable predictive marker of disease severity. Periostin is a matricellular protein involved in bone formation, remodeling, and response to mechanical stress. It interacts with type I collagen and modulates osteoblast activity via Wnt/β-catenin and TGF-β signaling. Given its established role in other bone disorders, we hypothesized that circulating periostin may be a relevant biomarker in OI. Methods: We performed a matched case–control analysis of serum periostin levels in 61 adult patients with OI and 61 age-, sex-, and BMI-matched controls. Periostin was measured by ELISA. Associations between periostin levels and clinical variables were assessed using t-tests, Pearson correlations, and multivariable linear regression models. Results: Mean periostin levels were significantly higher in OI patients than in controls (796.5 ± 209 vs 713.6 ± 167 pmol/L, P = .017). Among OI patients, higher periostin level was associated with female sex (P = .01), presence of scoliosis (P = .01), and Sillence type III (P = .05). Positive correlations were observed between periostin and markers of axial skeletal severity as height–wingspan discrepancy (r = 0.30, P = .023). In multivariable analysis, the number of severe fractures (defined as femur/pelvis/humerus/vertebral fractures) was independently associated with higher periostin level (β = 25.6, P = .041), while smoking was negatively associated (β = −269.8, P = .012). Conclusion: This study is the first to report the elevated circulating level of periostin in adults with OI and its association with disease severity.


  • Evaluation of circulating microRNA signature in patients with erosive hand osteoarthritis: The HOAmiR study

    by Maxime Auroux, Marjorie Millet, Blandine Merle, Elisabeth Fontanges, Florence Duvert, Evelyne Gineyts, Jean-Charles Rousseau, Olivier Borel, Alexandre Mercier-Guery, Eric Lespessailles, et al.


  • OPN, BSP, and Bone Quality—Structural, Biochemical, and Biomechanical Assessment in OPN−/−, BSP−/−, and DKO Mice

    by Luc Malaval, Hélène Follet, Delphine Farlay, Evelyne Gineyts, Sebastien Rizzo, Charlene Thomas, Mathieu Maalouf, Myriam Normand, Brigitte Burt-Pichat, Wafa Bouleftour, et al.

    Osteopontin (OPN) and Bone Sialoprotein (BSP), abundantly expressed by osteoblasts and osteoclasts, appear to have important, partly overlapping functions in bone. In gene-knockout (KO, -/-) models of either protein and their double (D)KO in the same CD1/129sv genetic background, we analyzed the morphology, matrix characteristics, and biomechanical properties of femur bone in 2 and 4 month old, male and female mice. OPN−/− mice display inconsistent, perhaps localized hypermineralization, while the BSP−/− are hypomineralized throughout ages and sexes, and the low mineralization of young DKO mice recovers with age. The higher contribution of primary bone remnants in OPN−/− shafts suggests a slow turnover, while their lower percentage in BSP−/− indicates rapid remodeling, despite FTIR-based evidence in this genotype of a high maturity of the mineralized matrix. In 3-point bending assays, OPN−/− bones consistently display higher Maximal Load, Work to Max. Load and in young mice Ultimate Stress, an intrinsic characteristic of the matrix. Young male and old female BSP−/− also display high Work to Max. Load along with low Ultimate Stress. Principal Component Analysis confirms the major role of morphological traits in mechanical competence, and evidences a grouping of the WT phenotype with the OPN−/− and of BSP−/− with DKO, driven by both structural and matrix parameters, suggesting that the presence or absence of BSP has the most profound effects on skeletal properties. Single or double gene KO of OPN and BSP thus have multiple distinct effects on skeletal phenotypes, confirming their importance in bone biology and their interplay in its regulation.


  • Open Access

    Serum Col3-4: A new type III and IV collagen biochemical marker of synovial tissue turnover in patients with rheumatoid arthritis

    by Evelyne Gineyts, Marjorie Millet, Olivier Borel, Frédéric Coutant, Jean-Charles Rousseau, Roland Chapurlat, Hubert Marotte, Patrick Garnero

    The objective of this study was to develop a serum biochemical marker of the degradation of type III and IV collagens, as an index of synovium turnover, and evaluate its performance in patients with rheumatoid arthritis (RA). An enzyme-linked immunosorbent assay for serum synovial collagen fragments (Col3-4) was developed using an antibody recognizing a specific sequence from human type III collagen, which shares 70% homology with type IV collagen. Immunohistochemistry was performed to localize Col3-4 and the matrix metalloprotease MMP-9 which is upregulated in RA synovial fibroblasts in the synovial tissue from a RA patient. Serum Col3-4 was measured in patients with RA (n = 66, 73% women, mean age 62 years, median disease activity score 28 with erythrocyte sedimentation rate (DAS28-ESR) 2.6) and in sex and age matched healthy controls (n = 70, 76% women, mean age 59 years). Col3-4 immunoassay demonstrated adequate analytical performances and recognized a circulating neoepitope resulting from the cleavage of type III and IV collagens. In RA synovium tissue, Col3-4 fragments were localized in the lining layer where destructive fibroblasts are present and around blood vessels rich in type IV collagen. MMP-9 colocalized with Col3-4 staining and efficiently released Col3-4 fragments from type III and type IV collagen digestion. Serum Col3-4 was markedly increased in patients with RA (+240% vs controls, p < 0.0001) and correlated with DAS28-ESR (r = 0.53, p < 0.0001). Patients with RA and active disease (DAS28-ESR > 3.2, n = 20) had 896% (p < 0.0001) higher levels than subjects with low activity (n = 46). Serum Col3-4 is a specific and sensitive biochemical marker reflecting MMP- mediated type III and IV collagen degradation from synovial tissue. Serum Col3-4 levels are markedly increased in patients with RA, particularly in those with active disease, suggesting that it may be useful for the clinical investigation of RA.


  • Open Access

    Serum SynCol as a new Biochemical Marker of Synovial Tissue Turnover in Patients with Rheumatoid Arthritis

    by Evelyne Gineyts, Marjorie Millet, Olivier Borel, Frédéric Coutant, Jean-Charles Rousseau, Roland Chapurlat, Hubert Marotte, Patrick Garnero

    BackgroundRheumatoid arthritis (RA) is characterized by synovium inflammation leading to joint destruction. No sensitive serum biochemical marker of synovial tissue activity is currently available. The aims of this study were to develop a new sensitive serum biochemical marker of synovium turnover and evaluate its performance in patients with RA.Methods We developed an enzyme-linked immunosorbent assay to measure synovial collagen fragments in serum (SynCol) using an antibody recognizing a specific 11 amino acid sequence from the triple helical portion of human type III collagen. The specificity of the antibody was evaluated by competitive inhibition with several collagen-related peptides. Immunohistochemistry was performed to localize the SynCol fragments in RA synovium. Serum SynCol was measured in patients with RA (n=66, 73% women, mean age 62 years, median disease activity score 28 (DAS 28) 2.6) participating in randomized clinical trials and in sex and age matched healthy controls (n=70, 76% women, mean age 59 years). ResultsThe SynCol ELISA demonstrated adequate analytical performances. Competitive inhibition experiments showed that the antibody used in the ELISA recognizes a neoepitope resulting from the cleavage of type III collagen molecules and also the homologous sequences of type IV collagen, but does not cross-react with intact type III and IV collagens. Immunohistochemistry of synovial tissue from a RA subject showed staining of SynCol fragments in the lining layer where destructive fibroblasts are localized and around blood vessels which are rich in type IV collagen. SynCol staining co-localized with matrix metalloproteinase 9 (MMP-9) immunostaining. Serum SynCol levels were significantly increased in patients with RA compared to healthy controls (+ 247 %, p Conclusions The SynCol ELISA is a sensitive and precise assay measuring circulating type III and IV collagen degradation fragments originating from synovial tissue turnover. Serum SynCol levels are markedly increased in patients with RA, particularly in those with active disease. Trial Registration- Role of the ANS Dysregulation in the Persistence of Fatigue in Rheumatoid Arthritis Patients Treated with Anti-TNF (ANSRA) NCT02475486- Bone MicroArchitecture Abatacept (BMA2) NCT02675218- Impact of the Persistence of Inflammation at Doppler Ultrasound Level on the Structural Evolution of Erosion in Rheumatoid Arthritis Treated with Biotherapy. NCT02531061IRB for synovial tissue 2019-A02742-55 (Comité de Protection des Personnes Sud-Méditerranée I

  • Open Access

    Ultrasounds could be considered as a future tool for probing growing bone properties

    by Emmanuelle Lefevre, Cécile Baron, Evelyne Gineyts, Yohann Bala, Hakim Gharbi, Jean-Marc Allain, Philippe Lasaygues, Martine Pithioux, Hélène Follet

    Juvenile bone growth is well described (physiological and anatomical) but there are still lacks of knowledge on intrinsic material properties. Our group has already published, on different samples, several studies on the assessment of intrinsic material properties of juvenile bone compared to material properties of adult bone. The purpose of this study was finally to combine different experimental modalities available (ultrasonic measurement, micro-Computed Tomography analysis, mechanical compression tests and biochemical measurements) applied on small cubic bone samples in order to gain insight into the multiparametric evaluation of bone quality. Differences were found between juvenile and adult groups in term of architectural parameters (Porosity Separation), Tissue Mineral Density (TMD), diagonal stiffness coefficients (C33, C44, C55, C66) and ratio between immature and mature cross-links (CX). Diagonal stiffness coefficients are more representative of the microstructural and biochemical parameters of child bone than of adult bone. We also found that compression modulus E was highly correlated with several microstructure parameters and CX in children group while it was not at all correlated in the adult group. Similar results were found for the CX which was linked to several microstructure parameters (TMD and E) only in the juvenile group. To our knowledge, this is the first time that, on a same sample, ultrasonic measurements have been combined with the assessment of mechanical and biochemical properties. It appears that ultrasonic measurements can provide relevant indicators of child bone quality (microstructural and biochemical parameters) which is promising for clinical application since, B-mode ultrasound is the preferred first-line modality over other more constraining imaging modalities (radiation, parent–child accessibility and access to the patient's bed) for pediatric patients.


  • Anisotropic elastic properties of human femoral cortical bone and relationships with composition and microstructure in elderly

    by Xiran Cai, Hélène Follet, Laura Peralta, Marc Gardegaront, Delphine Farlay, Rémy Gauthier, Boliang Yu, Evelyne Gineyts, Cécile Olivier, Max Langer, et al.


  • Deletion of OPN in BSP knockout mice does not correct bone hypomineralization but results in high bone turnover

    by W. Bouleftour, L. Juignet, L. Verdière, I. Machuca-Gayet, M. Thomas, N. Laroche, A. Vanden-Bossche, D. Farlay, C. Thomas, E. Gineyts, et al.


  • Spatial Distribution of Microcracks in Osteoarthritic Femoral Neck: Influence of Osteophytes on Microcrack Formation

    by Gustavo D. Rabelo, Nathalie Portero-Muzy, Evelyne Gineyts, Jean-Paul Roux, Roland Chapurlat, Pascale Chavassieux

    Osteophytes have been suggested to influence the bone mechanical properties. The aim of this study was to compare the microcrack density in osteophytes with that in the other parts of the osteoarthritic femoral neck (FN). The presence of microcracks was investigated in the ultra-distal FN and in the osteophytes in samples obtained during hip arthroplasty in 24 postmenopausal women aged 67 ± 10 years. Furthermore, the 3D microarchitecture and the collagen crosslinks contents were assessed by high-resolution peripheral quantitative computed tomography and high-performance liquid chromatography, respectively. Osteophytes were present in the 24 FN, mainly at the level of the inferior quadrant. Microcracks were present in all FN with an average of 2.8 per sample. All observed microcracks were linear. The microcrack density (Cr.N/BV; #/mm2) was significantly higher in cancellous than in cortical bone (p = 0.004), whereas the microcrack length (Cr.Le, µm) was significantly greater in cortical bone (p = 0.04). The collagen crosslinks ratio pyridinoline/deoxypyridinoline was significantly and negatively correlated with Cr.N/BV in the posterior (r′ = − 0.68, p = 0.01) and inferior (r′ = − 0.53, p = 0.05) quadrants. Microcracks were observed in seven osteophytes in seven patients. When microcracks were present in the osteophyte area, Cr.N/BV was also significantly higher in the whole FN and in the quadrant of the osteophyte compared to the cases without microcrack in the osteophyte (p < 0.03). In conclusion, in FN from hip osteoarthritis microcracks are present in all FNs but in only 23% of the osteophytes. The microcrack formation was greater and their progression was smaller in the cancellous bone than in the cortex. The spatial distribution of microcracks varied according to the proximity of the osteophyte, and suggests that osteophyte may influence microcrack formation related to changes in local bone quality.


  • Relationships between human cortical bone toughness and collagen cross-links on paired anatomical locations

    by Rémy Gauthier, Hélène Follet, Max Langer, Evelyne Gineyts, Frédéric Rongiéras, Françoise Peyrin, David Mitton